Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Classificação em ações #17187
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Preço da ação
$2.20
Última sincronização: 2026-09-01
Valor de mercado
$253.81M
Variação (1 dia)
10.29%
Variação (1 ano)
99.67%
País
CA
Negociar Cardiol Therapeutics Inc. (CRDL)

Categoria

Preço CRDL com a capitalização de mercado de B
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
CRDL
$2.20
Capitalização de mercado de Cardiol Therapeutics Inc.(CRDL)
Valor de mercado: $253.81M
Em September 2026, Cardiol Therapeutics Inc. tem uma capitalização de mercado de $253.81M. Isso faz com que Cardiol Therapeutics Inc. seja a 17187th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Cardiol Therapeutics Inc. de 2018 a 2026
CRDL comparado com o topo de 5 mais populares stocks
Preço para CRDL Ativo B Capitalização de mercado de B Resultados
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$45,627.72 $253.81M
$5.260T +2,072,181.83%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$41,454.31 $253.81M
$4.779T +1,882,637.41%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$34,845.69 $253.81M
$4.017T +1,582,492.63%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$32,265.44 $253.81M
$3.719T +1,465,304.86%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$23,719.85 $253.81M
$2.734T +1,077,188.17%